Tag : Pharmas

Latest News

New data show that LEO Pharma’s Kyntheum® (brodalumab) sustains PASI 100 scores longer than ustekinumab for people with moderate-to-severe plaque psoriasis

Newsemia
BALLERUP, Denmark–(BUSINESS WIRE)–New data show that LEO Pharma’s Kyntheum® sustains PASI 100 scores longer than ustekinumab for people with moderate-to-severe plaque psoriasis Source link...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy